Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus

NCT00003054 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

NETWORK

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: paclitaxel

Sponsor

Gynecologic Oncology Group

Collaborators

[object Object]